GLG News in Healthcare
August 7, 2008
I totally agree with the fact that currently the dermataologists are avoiding the skin cancer patients in favor of the filler and Botox cleients. If howver the third party insurers would compensate the physicians for their skin lesion removals properly this might not be occuring a sit is.
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
There is more to esthetics than just the use of lasers and fillers...and a well trained plastic surgeon can give a far broader number of options to the patient than a family physician or gynecologist If the derms want to do this skin rejuvenation....who is to treat rosacea,acne skin cancer and melanoma..... From an overall safety standpoint,the public is being put at risk by seeking...
August 7, 2008
why not do cosmetic surgery/procedures? why not get paid?
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
without question, medicine has changed. dermatologists and plastic surgeons can make considerably more money, and be paid in cash by catering to "cosmetic" patients. No wonder fewer and fewer surgeons/dermatologists are interested in treating skin cancers, scars, lacerations etc. Why get paid 25 cents on the dollar when you can get fee for service with patients interested in...
August 6, 2008
as medicine becomes an expected no cost right it looses value & reimbursement
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: As Doctors Cater to Looks, Skin Patients Wait | www.nytimes.com
Author: GLG Expert Contributor
With excellent patient satisfaction, ease of use and excellent cash based reimbursement, there is a rapidly growing aesthetic & skin care business to dermatologic practice. This has clearly impacted access to care by patients with skin disease in my area. Perhaps a better question is why should we expect otherwise?
August 6, 2008
HIV drugs can not be used as prevention
Analysis of: Researchers Look to Pill, Taken Daily, to Avert H.I.V. | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Researchers Look to Pill, Taken Daily, to Avert H.I.V. | www.nytimes.com
Author: GLG Expert Contributor
1.PrEP involves a prescription drug, so it’s likely that initial programs will be clinic-based. PrEP delivery would also require periodic HIV testing. 2. In contrast to male circumcision—or hopefully one day, a vaccine—PrEP would require that people take a drug on an ongoing basis (daily or intermittently). 3. Interest in PrEP could bring more individuals into the health clinic, where they would have...
August 6, 2008
Concerns about the Rember Phase 2 data
Analysis of: New Treatment Halts Progress of Alzheimer's Disease | www.abdn.ac.uk
Author: GLG Expert Contributor
Analysis of: New Treatment Halts Progress of Alzheimer's Disease | www.abdn.ac.uk
Author: GLG Expert Contributor
While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.
August 6, 2008
Boy will this p.... off Urologists as well as AARP!
Analysis of: Panel Urges End to Prostate Screening at Age 75 | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Panel Urges End to Prostate Screening at Age 75 | www.nytimes.com
Author: GLG Expert Contributor
Since treatment may be worse than the disease it is being recommended that routine prostate cancer screening be stopped after the age of 75.
August 6, 2008
At What Cost Prevention?
Analysis of: Researchers Look to Pill, Taken Daily, to Avert H.I.V. | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Researchers Look to Pill, Taken Daily, to Avert H.I.V. | www.nytimes.com
Author: GLG Expert Contributor
There is already a bounty of data to support anti-retroviral (and other) HIV medications in post-exposure prophylaxis, be it in infants born to HIV-positive mothers; intra-partum prophylaxis to HIV-positive women in active labor; and to healthcare workers (and others) exposed to HIV from accidental needlesticks and other exposures. Pre-exposure prophylaxis is simply a broadening of post-exposure...
August 6, 2008
More questions than answers:
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
Should bisphosphonates be stopped in patients who have been taking them for many years? Should they be used at all?
August 6, 2008
Healthcare Consumers Are More Savvy
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor
The article is based upon the premise that U.S. pharmacies are reporting fewer filled prescriptions. Many Americans have determined correctly that filling their prescriptions via the Internet from mail-order and foreign outlets is less expensive. Other Americans simply cannot afford the high cost of many medications and are going without or receive sufficient supplies from their physicians. The healthcare...
August 6, 2008Hospital transparency an illusive ideal
Analysis of: Transparency in Healthcare | www.hospitalimpact.org
Author: Steve Davis, Director of Radiology, Clarendon Memorial Hospital Inc
Patients requiring health care today demand quality. Quality from their physician, their diagnostic services, and the insurance companies.CMS already mandates certain levels of quality and hospitals. They assure these quality levels by doing spot inspections, and also contracting with the joint commission, which mandates certain levels of care in order to get paid by CMS. Most patients...
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
FDA Alert: Hemorrhagic or Necrotizing Pancreatitis in Patients Taking Byetta
www.fda.gov
Healthways' Guidance Not So Healthy
www.forbes.com
Drug Makers’ Push Leads to Cancer Vaccines’ Fast Rise
www.nytimes.com
Hospital Death Rates Unveiled for First-Time Comparison
www.usatoday.com
Temozolomide And Thalidomide Combination Effective Against Malignant Melanoma Spread To CNS And White Blood Cell Count May Be Prognostic
www.medicalnewstoday.com
Its all about the spin
August 21, 2008
Byetta sale will reduce after FAD alert
August 19, 2008
PCI numbers will not drop after Courage
August 19, 2008
Bad News (but not new news) for stents.
August 19, 2008
Less and less evidence to favor coronary stenting
August 15, 2008

